aTyr Pharma
ATYR
25 hedge funds and large institutions have $18.5M invested in aTyr Pharma in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 4 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 2
0% more funds holding
Funds holding: 25 → 25 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
1.86% less ownership
Funds ownership: 59.86% → 58% (-1.9%)
25% less capital invested
Capital invested by funds: $24.9M → $18.5M (-$6.33M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$358K |
| 2 |
Renaissance Technologies
New York
|
+$175K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$109K |
| 4 |
Millennium Management
New York
|
+$93.5K |
| 5 |
Two Sigma Investments
New York
|
+$83.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$158K |
| 2 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$100K |
| 3 |
OC
Oppenheimer & Co
New York
|
-$81K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$53K |
| 5 |
Morgan Stanley
New York
|
-$9.99K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| – | +$4 | +1 | +20% |
|
27
Wells Fargo
San Francisco,
California
| – | +$8 | +2 | +4% |
|
|
KCM
28
Kathmere Capital Management
Wayne,
Pennsylvania
| – | +$41 | +10 | New |
|
ATYR Hedge Fund Activity: Q3 2020 in Review
25 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in aTyr Pharma (ATYR) for Q3 2020, worth a combined $18.5M — down 25% from $24.9M a quarter earlier.
Fund positioning in ATYR was balanced in Q3 2020: 4 funds opened new positions, 4 closed out, 10 added to existing stakes and 2 trimmed.
The largest buyer was Two Sigma Advisers, adding an estimated $358K. The largest seller was UBS Group, cutting an estimated $158K.
- 25 institutional investors held aTyr Pharma (ATYR) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $18.5M of aTyr Pharma stock for Q3 2020, down 25% quarter-over-quarter.
- 4 funds opened new aTyr Pharma positions in Q3 2020 and 4 closed out, a net change of 0 holders.
- The largest aTyr Pharma buyer in Q3 2020 was Two Sigma Advisers, an estimated $358K added.
- The largest aTyr Pharma seller in Q3 2020 was UBS Group, an estimated $158K sold.
Based on aggregated 13F filings for Q3 2020.